50 Years experience with Dupuytren's contracture in the Erlangen University Hospital - A retrospective analysis of 2919 operated hands from 1956 to 2006

BMC Musculoskeletal Disorders

Volumn 8, Issue , 2007, Pages

  Loos, Bernd ^a   Puschkin, Valerij ^a   Horch, Raymund E ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BLEEDING; BLOOD VESSEL INJURY; COHORT ANALYSIS; COMPARATIVE STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; DOCUMENTATION; DUPUYTREN CONTRACTURE; EPILEPSY; EVALUATION; EXPERIENCE; FEMALE; HAND; HAND SURGERY; HUMAN; INFORMATION PROCESSING; KNOWLEDGE; LEFT HANDEDNESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RECORD REVIEW; NERVE INJURY; POPULATION; PREVALENCE; RETROSPECTIVE STUDY; RIGHT HANDEDNESS; RISK FACTOR; SKIN NECROSIS; SMOKING; STATISTICAL ANALYSIS; TENDON INJURY; UNIVERSITY HOSPITAL; WOUND INFECTION; DRINKING BEHAVIOR; GERMANY; MIDDLE AGED; ONSET AGE;

ADULT; AGE OF ONSET; AGED; ALCOHOL DRINKING; DIABETES COMPLICATIONS; DUPUYTREN'S CONTRACTURE; EPILEPSY; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 34548166261     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-8-60     Document Type: Article

References (54)

1. Four related fibrosing diseases. When you find one, look for another. WE Wooldridge, Postgrad Med 1988 84 2 269 271 274 3399468
2. Permanent retraction of the fingers, produced by an affection of the palmar fascia. G Dupuytren, Lancet 1834 ii 222 225
3. N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling. J Kopp H Seyhan B Muller J Lanczak E Pausch AM Gressner S Dooley RE Horch, J Cell Mol Med 2006 10 1 157 165 10.1111/j.1582-4934.2006.tb00297.x 16563228
4. Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture. H Seyhan J Kopp S Schultze-Mosgau RE Horch, Plast Reconstr Surg 2006 117 4 1248 1252 10.1097/01.prs.0000204585.97844.7e 16582795
5. Prevalence of Dupuytren's contracture and its correlation with degenerative changes of the hands and feet and with criteria of general health. H Bergenudd F Lindgarde BE Nilsson, J Hand Surg [Br] 1993 18 2 254 257 10.1016/0266-7681(93)90123-W 8501389
6. Dupuytren contracture in North Germany. Epidemiological study of 500 cases. P Brenner A Krause-Bergmann VH Van, Unfallchirurg 2001 104 4 303 311 10.1007/s001130050732 11357696
7. Epidemiological and structural findings supporting the fibromatous origin of dorsal knuckle pads. A Caroli S Zanasi A Marcuzzi D Guerra G Cristiani IP Ronchetti, J Hand Surg [Br] 1991 16 3 258 262 10.1016/0266-7681(91)90049-T 1960489
8. Dupuytren's contracture in pensioners at the Royal Hospital Chelsea. J Carson C Clarke, J R Coll Physicians Lond 1993 27 1 25 27 8426337
9. Epidemiology of Dupuytren's disease: clinical, serological, and social assessment. The Reykjavik Study. KG Gudmundsson R Arngrimsson N Sigfusson A Bjornsson T Jonsson, J Clin Epidemiol 2000 53 3 291 296 10.1016/S0895-4356(99) 00145-6 10760640
10. [The role of occupational and dispositional factors in the development of Dupuytren contracture]. J Marx W Schunk, Beitr Orthop Traumatol 1982 29 9 477 483 7150219
11. The prevalence of Dupuytren's disease in Norway. A study in a representative population sample of the municipality of Haugesund. OA Mikkelsen, Acta Chir Scand 1972 138 7 695 700 4642708
12. Aetiology of Dupuytren's contracture. GA Murrell JT Hueston, Aust N Z J Surg 1990 60 4 247 252 2322211
13. Epidemiology of Dupuytren's disease. DC Ross, Hand Clin 1999 15 1 53 62 vi 10050242
14. Dupuytren's disease: a legacy of the north? DC Whaley D Elliot, J Hand Surg [Br] 1993 18 3 363 367 10.1016/0266-7681(93)90065-N 8345270
15. Dupuytren's contractures in a black patient in East Africa. DW Furnas, Plast Reconstr Surg 1979 64 2 250 251 10.1097/00006534-197908000-00021 451085
16. Dupuytren's contracture in the Negro. U Mennen, J Hand Surg [Br] 1986 11 1 61 64 10.1016/0266-7681(86)90015-X 3958551
17. Dupuytren's contracture in the black population: a case report and review of the literature. MS Sladicka P Benfanti M Raab J Becton, J Hand Surg [Am] 1996 21 5 898 899 10.1016/S0363-5023(96)80211-5 8891992
18. Dupuytren's contracture in Thailand. P Vathana A Setpakdi T Srimongkol, Bull Hosp Jt Dis Orthop Inst 1990 50 1 41 47 2163703
19. Dupuytren's disease in Bosnia and Herzegovina. An epidemiological study. D Zerajic V Finsen, BMC Musculoskelet Disord 2004 5 10 15050031 10.1186/1471-2474-5-10
20. The Genetic Factor in Dupuytren's Disease. RS Ling, J Bone Joint Surg Br 1963 45 709 718 14074318
21. Clonal chromosome abnormalities in a so-called Dupuytren's subungual exostosis. P Dal Cin P Pauwels LJ Poldermans R Sciot H Van den Berghe, Genes Chromosomes Cancer 1999 24 2 162 164 10.1002/(SICI)1098-2264(199902)24:2<162: :AID-GCC11>3.0.CO;2-7 9885985
22. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology. I De Wever P Dal Cin CD Fletcher N Mandahl F Mertens F Mitelman J Rosai A Rydholm R Sciot G Tallini H Van Den Berghe R Vanni H Willén, Mod Pathol 2000 13 10 1080 1085 10.1038/modpathol.3880200 11048801
23. Increased total mortality and cancer mortality in men with Dupuytren's disease: a 15-year follow-up study. KG Gudmundsson R Arngrimsson N Sigfusson T Jonsson, J Clin Epidemiol 2002 55 1 5 10 10.1016/S0895-4356(01)00413-9 11781116
24. Is diabetes mellitus type 2 a risk factor for Dupuytren's contracture in the Mediterranean region? A Akyol N Kiylioglu E Copcu E Guney A Aydeniz, Plast Reconstr Surg 2006 117 6 2105 2106 10.1097/01.prs.0000214746.17066.2e 16652017
25. Dupuytren's contracture in manual workers. B Bennett, Br J Ind Med 1982 39 1 98 100 7066227
26. Smoking, alcohol and the risk of Dupuytren's contracture. P Burge G Hoy P Regan R Milne, J Bone Joint Surg Br 1997 79 2 206 210 10.1302/0301-620X.79B2. 6990 9119843
27. Dupuytren's disease risk factors. JM Geoghegan J Forbes DI Clark C Smith R Hubbard, J Hand Surg [Br] 2004 29 5 423 426 10.1016/j.jhsb.2004.06.006 15336742
28. A prospective study linked both alcohol and tobacco to Dupuytren's disease. NS Godtfredsen H Lucht E Prescott TI Sorensen M Gronbaek, J Clin Epidemiol 2004 57 8 858 863 10.1016/j.jclinepi.2003.11.015 15485739
29. Dupuytren's disease, alcohol consumption and alcoholism. KG Gudmundsson R Arngrimsson T Jonsson, Scand J Prim Health Care 2001 19 3 186 190 10.1080/028134301316982441 11697563
30. Dupuytren's disease in type 1 diabetic patients: a five-year prospective study. PE Arkkila IM Kantola JS Viikari T Ronnemaa MA Vahatalo, Clin Exp Rheumatol 1996 14 1 59 65 8697659
31. Risks and prevention of Dupuytren's contracture. M Frey, Lancet 1997 350 9091 1568 10.1016/S0140-6736(05)64010-X 9393334
32. A review of common practice in Dupuytren surgery. IT Au-Yong CJ Wildin JJ Dias RE Page, Tech Hand Up Extrem Surg 2005 9 4 178 187 10.1097/01.bth. 0000186794.90431.a4 16340578
33. Chirurgie der Hand. M Iselin, Stuttgart: Thieme 1965 1
34. [Postoperative complications in Dupuytren's disease]. M Iselin F Iselin, Mem Acad Chir (Paris) 1966 92 8 240 246 5906956
35. [Dupuytren's contracture - is partial palmar aponeurectomy still justifiable?]. R Langenberg, Zentralbl Chir 1987 112 12 769 775 2442921
36. Results following surgery for recurrent Dupuytren's disease. TF Roush PJ Stern, J Hand Surg [Am] 2000 25 2 291 296 10.1053/jhsu.2000.jhsu25a0291 10722821
37. The surgical treatment of Dupuytren's contracture: a synthesis of techniques. HD Skoff, Plast Reconstr Surg 2004 113 2 540 544 10.1097/01.PRS.0000101054.80392.88 14758215
38. A natural history of Dupuytren's contracture treated by surgical fasciectomy: the influence of diathesis (76 hands reviewed at more than 10 years). JP Vigroux P Valentin, Ann Chir Main Memb Super 1992 11 5 367 374 10.1016/S0753-9053(05)80272-8 1284017
39. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. S Wilbrand A Ekbom B Gerdin, J Hand Surg [Br] 1999 24 4 456 459 10.1054/jhsb.1999.0154 10473157
40. Dupuytren's contracture: the significance of various factors in its etiology. S Gordon, Ann Surg 1954 140 5 683 686 13208116 10.1097/00000658- 195411000-00007
41. Oestrogen and progesterone hormone receptors in Dupuytren's disease. FM Hankin J Eckenrode DS Louis, J Hand Surg [Br] 1986 11 3 463 464 10.1016/0266-7681(86)90184-1 3794501
42. Dupuytren's disease. SG Childs, Orthop Nurs 2005 24 2 160 163 quiz 164-165 10.1097/00006416-200503000-00014 15902016
43. On the pathogenesis and therapy of Dupuytren's contracture. (A study based on more than 500 cases). H Millesi, Ergeb Chir Orthop 1965 47 51 101
44. Ulnar-Tunnel Syndrome at the Wrist. a Report of Four Cases Ulnar-Nerve Compression at the Wrist. C Dupont GE Cloutier Y Prevost MA Dion, J Bone Joint Surg Am 1965 47 757 761 14299666
45. Current surgical treatment of Dupuytren's disease. GR Wilson, Br J Clin Pract 1997 51 2 106 110 9158254
46. Dupuytren's contracture in the course of internal diseases. G Jonderko M Bednarczyk-Kaluzny E Dyczek-Parys A Niedziela-Pokrzyk K Jonderko B Pitlok, Pol Tyg Lek 1982 37 6 159 161 7122310
47. A retrospective review of the management of Dupuytren's nodules. RM Reilly PJ Stern CA Goldfarb, J Hand Surg [Am] 2005 30 5 1014 1018 10.1016/j.jhsa.2005.03.005 16182060
48. Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. H Seyhan J Hamzavi E Wiercinska AM Gressner PR Mertens J Kopp RE Horch K Breitkopf S Dooley, J Cell Mol Med 2006 10 4 922 32 17125595
49. Gene transfer strategies in tissue engineering. O Bleiziffer E Eriksson F Yao RE Horch U Kneser, J Cell Mol Med 2007 11 2 206 23 10.1111/j.1582-4934. 2007.00027.x 17488473
50. Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science. E Polykandriotis A Arkudas RE Horch M Sturzl U Kneser, J Cell Mol Med 2007 11 1 6 20 Review 10.1111/j.1582-4934.2007.00012.x 17367498
51. A new approach to tissue engineering of vascularized skeletal muscle. AD Bach A Arkudas J Tjiawi E Polykandriotis U Kneser RE Horch JP Beier, J Cell Mol Med 2006 10 3 716 26 10.1111/j.1582-4934.2006.tb00431.x 16989731
52. N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling. J Kopp H Seyhan B Muller J Lanczak E Pausch AM Gressner S Dooley RE Horch, J Cell Mol Med 2006 10 1 157 65 10.1111/j.1582-4934.2006.tb00297.x 16563228
53. Future perspectives in tissue engineering. RE Horch, J Cell Mol Med 2006 10 1 4 6 10.1111/j.1582-4934.2006.tb00286.x 16563217
54. Complex regional pain syndrome type I (CRPS type I/"RSD") - an overview. A Arkudas U Kneser RE Horch, Zentralbl Chir 2006 131 3 W40 8 16739055